These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19026648)

  • 1. The accelerating pace of HCV research: a summary of the 15th International Symposium on Hepatitis C Virus And Related Viruses.
    Lanford RE; Evans MJ; Lohmann V; Lindenbach B; Gale M; Rehermann B; Chang KM; Lemon SM
    Gastroenterology; 2009 Jan; 136(1):9-16. PubMed ID: 19026648
    [No Abstract]   [Full Text] [Related]  

  • 2. The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses.
    Shin EC; Han JW; Kang W; Kato T; Kim SJ; Zhong J; Kim S; Park SH; Sung PS; Watashi K; Park JY; Windisch MP; Oh JW; Wakita T; Han KH; Jang SK
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32168867
    [No Abstract]   [Full Text] [Related]  

  • 3. Addressing the next challenges: A summary of the 22nd international symposium on hepatitis C virus and related viruses.
    Baumert TF; Schuster C; Cosset FL; Dubuisson J; Hofmann M; Tautz N; Zeisel MB; Thimme R
    J Hepatol; 2016 Apr; 64(4):968-73. PubMed ID: 26780288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immunity against hepatitis C virus.
    Xu Y; Zhong J
    Curr Opin Immunol; 2016 Oct; 42():98-104. PubMed ID: 27366996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus and hepatocellular carcinoma.
    Colombo M
    Baillieres Best Pract Res Clin Gastroenterol; 1999 Dec; 13(4):519-28. PubMed ID: 10654917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transition of antibody to hepatitis C virus from chronic hepatitis to hepatocellular carcinoma.
    Kiyosawa K; Tanaka E; Sodeyama T; Furuta K; Usuda S; Yousuf M; Furuta S
    Jpn J Cancer Res; 1990 Nov; 81(11):1089-91. PubMed ID: 2176199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuralized E3 Ubiquitin Protein Ligase 3 Is an Inducible Antiviral Effector That Inhibits Hepatitis C Virus Assembly by Targeting Viral E1 Glycoprotein.
    Zhao Y; Cao X; Guo M; Wang X; Yu T; Ye L; Han L; Hei L; Tao W; Tong Y; Xu Y; Zhong J
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection.
    Di Bisceglie AM; Simpson LH; Lotze MT; Hoofnagle JH
    J Clin Gastroenterol; 1994 Oct; 19(3):222-6. PubMed ID: 7528758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the inflammation in HCV-associated hepatocellular carcinoma: a role in the prevention and treatment.
    Castello G; Costantini S; Scala S
    J Transl Med; 2010 Nov; 8():109. PubMed ID: 21047421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between hepatocellular carcinoma and hepatitis B and C virus.
    Kohli A
    Clin Adv Hematol Oncol; 2016 Feb; 14(2):96-8. PubMed ID: 27057807
    [No Abstract]   [Full Text] [Related]  

  • 11. A summary of the 20th International Symposium on Hepatitis C Virus and Related Viruses.
    Beard MR; Ffrench R; Gowans EJ; Helbig KJ; Eyre NM; Douglas MM; Grebely J; Ahlenstiel G; Locarnini S; George J; Shackel NA; White PA; Thompson AJ; Drummer HE
    Gastroenterology; 2014 Jul; 147(1):e1-4. PubMed ID: 24861641
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of hepatocellular carcinoma after clearance of hepatitis C virus with interferon therapy.
    Tong MJ; Lai LP; Murakami-Mori K
    West J Med; 1997 Aug; 167(2):103-5. PubMed ID: 9291751
    [No Abstract]   [Full Text] [Related]  

  • 13. [Update on hepatitis C virus: its variability and the implications].
    Lunel F; Stuyver L; Brechot C; Maertens G
    Transfus Clin Biol; 1998 Apr; 5(2):147-65. PubMed ID: 9618840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systems biology analysis of hepatitis C virus infection reveals the role of copy number increases in regions of chromosome 1q in hepatocellular carcinoma metabolism.
    Elsemman IE; Mardinoglu A; Shoaie S; Soliman TH; Nielsen J
    Mol Biosyst; 2016 Apr; 12(5):1496-506. PubMed ID: 27040643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of hepatitis C virus infection in Korea.
    Suh DJ; Jeong SH
    Intervirology; 2006; 49(1-2):70-5. PubMed ID: 16166792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HCV infection among cirrhotic patients as a risk factor for generation of hepatocellular carcinoma: preliminary report].
    Kobayashi S; Nagai Y; Nakao T; Nogami H; Isono K
    Nihon Geka Gakkai Zasshi; 1991 Nov; 92(11):1666. PubMed ID: 1722866
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatitis C virus and hepatocellular carcinoma.
    Kiyosawa K; Furuta S
    Curr Stud Hematol Blood Transfus; 1994; (61):98-120. PubMed ID: 7525158
    [No Abstract]   [Full Text] [Related]  

  • 18. HCV-associated hepatocellular carcinoma without cirrhosis.
    el-Refaie A; Savage K; Bhattacharya S; Khakoo S; Harrison TJ; el-Batanony M; Soliman el-S ; Nasr S; Mokhtar N; Amer K; Scheuer PJ; Dhillon AP
    J Hepatol; 1996 Mar; 24(3):277-85. PubMed ID: 8778193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology, risk factors, and natural history of hepatocellular carcinoma.
    Montalto G; Cervello M; Giannitrapani L; Dantona F; Terranova A; Castagnetta LA
    Ann N Y Acad Sci; 2002 Jun; 963():13-20. PubMed ID: 12095924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma complicating autoimmune hepatitis: role of hepatitis C virus.
    Ryder SD; Koskinas J; Rizzi PM; McFarlane IG; Portmann BC; Naoumov NV; Williams R
    Hepatology; 1995 Sep; 22(3):718-22. PubMed ID: 7657274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.